
Abbott Laboratories
ABT126.380USD
-3.510-2.70%
Horarios del mercado 03/14, 14:37(ET)Cotizaciones retrasadas 15 min
218.85BCap. mercado
16.33P/E TTM
Información de Abbott Laboratories Compañía
Información de la empresa
Código de la empresaABT
Nombre de la empresaAbbott Laboratories
Fecha de salida a bolsaMar 01, 1937
Fundada en1900
Director ejecutivoMr. Robert B. Ford
Número de empleados114000
Tipo de títulosOrdinary Share
Fin del año fiscalMar 01
Dirección100 Abbott Park Road
CiudadABBOTT PARK
Bolsa de valoresNYSE Consolidated
PaísUnited States of America
Código postal60064-3500
Teléfono12246676100
Sitio Webhttps://www.abbott.com
Código de la empresaABT
Fecha de salida a bolsaMar 01, 1937
Fundada en1900
Ejecutivos de la empresa
Nombre
Nombre/Posición
Posición
Accionados
Cambio
Mr. Daniel J. Starks
Mr. Daniel J. Starks
Independent Director
Independent Director
6.72M
+0.03%
Mr. Hubert L. Allen
Mr. Hubert L. Allen
Executive Vice President, General Counsel, Secretary
Executive Vice President, General Counsel, Secretary
191.89K
+3.84%
Mr. Daniel Gesua Sive Salvadori
Mr. Daniel Gesua Sive Salvadori
Executive Vice President, Group President - Established Pharmaceuticals and Nutritional Products
Executive Vice President, Group President - Established Pharmaceuticals and Nutritional Products
133.76K
+6.42%
Ms. Mary K. Moreland
Ms. Mary K. Moreland
Executive Vice President - Human Resources
Executive Vice President - Human Resources
95.58K
-0.82%
Ms. Lisa D. Earnhardt
Ms. Lisa D. Earnhardt
Executive Vice President, Group President - Medical Devices
Executive Vice President, Group President - Medical Devices
71.92K
--
Mr. Louis H. Morrone
Mr. Louis H. Morrone
Executive Vice President - Core Diagnostics
Executive Vice President - Core Diagnostics
66.87K
-1.63%
Mr. Philip P. Boudreau
Mr. Philip P. Boudreau
Chief Financial Officer, Executive Vice President - Finance
Chief Financial Officer, Executive Vice President - Finance
56.90K
+44.73%
Dr. Robert J. Alpern, M.D.
Dr. Robert J. Alpern, M.D.
Independent Director
Independent Director
39.16K
+5.00%
Ms. Nancy Mckinstry
Ms. Nancy Mckinstry
Lead Independent Director
Lead Independent Director
37.08K
+5.30%
Ms. Sally E. Blount, Ph.D.
Ms. Sally E. Blount, Ph.D.
Independent Director
Independent Director
35.02K
+5.63%
Ver más
Nombre
Nombre/Posición
Posición
Accionados
Cambio
Mr. Daniel J. Starks
Mr. Daniel J. Starks
Independent Director
Independent Director
6.72M
+0.03%
Mr. Hubert L. Allen
Mr. Hubert L. Allen
Executive Vice President, General Counsel, Secretary
Executive Vice President, General Counsel, Secretary
191.89K
+3.84%
Mr. Daniel Gesua Sive Salvadori
Mr. Daniel Gesua Sive Salvadori
Executive Vice President, Group President - Established Pharmaceuticals and Nutritional Products
Executive Vice President, Group President - Established Pharmaceuticals and Nutritional Products
133.76K
+6.42%
Ms. Mary K. Moreland
Ms. Mary K. Moreland
Executive Vice President - Human Resources
Executive Vice President - Human Resources
95.58K
-0.82%
Ms. Lisa D. Earnhardt
Ms. Lisa D. Earnhardt
Executive Vice President, Group President - Medical Devices
Executive Vice President, Group President - Medical Devices
71.92K
--
Mr. Louis H. Morrone
Mr. Louis H. Morrone
Executive Vice President - Core Diagnostics
Executive Vice President - Core Diagnostics
66.87K
-1.63%
Desglose de ingresos
Divisa: USDHora de actualización: mié., 5 de mar
Divisa: USDHora de actualización: mié., 5 de mar
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
Por negocioUSD
Nombre
Ganancia
Proporción
Diabetes Care
6.80B
16.22%
Core Laboratory
5.23B
12.47%
Adult Nutritionals
4.38B
10.46%
Pediatric Nutritionals
4.02B
9.58%
Key Emerging Markets
3.85B
9.19%
Other
17.63B
42.04%
Por regiónUSD
Nombre
Ganancia
Proporción
United States
16.32B
38.91%
All other Countries
14.84B
35.38%
Germany
2.53B
6.05%
China
2.11B
5.03%
India
1.81B
4.33%
Other
4.31B
10.27%
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
Diabetes Care
6.80B
16.22%
Core Laboratory
5.23B
12.47%
Adult Nutritionals
4.38B
10.46%
Pediatric Nutritionals
4.02B
9.58%
Key Emerging Markets
3.85B
9.19%
Other
17.63B
42.04%
Accionista
Hora de actualización: dom., 9 de feb
Hora de actualización: dom., 9 de feb
Estadísticas de accionistas
Tipo
Estadísticas de accionistas
Accionista
Proporción
The Vanguard Group, Inc.
9.68%
BlackRock Institutional Trust Company, N.A.
5.02%
State Street Global Advisors (US)
4.44%
Capital International Investors
3.91%
Capital Research Global Investors
3.11%
Other
73.81%
Estadísticas de accionistas
Accionista
Proporción
The Vanguard Group, Inc.
9.68%
BlackRock Institutional Trust Company, N.A.
5.02%
State Street Global Advisors (US)
4.44%
Capital International Investors
3.91%
Capital Research Global Investors
3.11%
Other
73.81%
Tipo
Accionista
Proporción
Investment Advisor
35.36%
Investment Advisor/Hedge Fund
32.70%
Research Firm
3.25%
Pension Fund
2.27%
Bank and Trust
2.13%
Sovereign Wealth Fund
1.31%
Insurance Company
0.99%
Hedge Fund
0.88%
Individual Investor
0.48%
Other
20.60%
Participación institucional
Hora de actualización: dom., 19 de ene
Hora de actualización: dom., 19 de ene
Periodo de informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q1
4397
1.38B
80.06%
+15.95M
2024Q4
4535
1.39B
80.22%
+15.89M
2024Q3
4391
1.35B
78.29%
-11.85M
2024Q2
4400
1.36B
78.24%
-7.02M
2024Q1
4402
1.35B
77.67%
-9.71M
2023Q4
4429
1.34B
77.56%
-11.05M
2023Q3
4298
1.34B
77.39%
-25.33M
2023Q2
4297
1.34B
77.60%
-13.54M
2023Q1
4281
1.34B
77.46%
-8.60M
2022Q4
4258
1.33B
76.84%
-15.37M
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
The Vanguard Group, Inc.
167.89M
9.68%
+762.53K
+0.45%
Dec 31, 2024
BlackRock Institutional Trust Company, N.A.
87.06M
5.02%
+811.84K
+0.94%
Dec 31, 2024
State Street Global Advisors (US)
77.16M
4.44%
+447.25K
+0.58%
Dec 31, 2024
Capital International Investors
67.97M
3.91%
+2.22M
+3.39%
Dec 31, 2024
Capital Research Global Investors
54.09M
3.11%
+795.07K
+1.49%
Dec 31, 2024
Geode Capital Management, L.L.C.
35.66M
2.05%
+765.63K
+2.19%
Dec 31, 2024
Wellington Management Company, LLP
26.39M
1.52%
+581.32K
+2.25%
Dec 31, 2024
JP Morgan Asset Management
25.13M
1.44%
+5.10M
+25.50%
Dec 31, 2024
Norges Bank Investment Management (NBIM)
20.98M
1.2%
+626.71K
+3.07%
Dec 31, 2024
Wells Fargo Advisors
15.25M
0.87%
-105.39K
-0.68%
Dec 31, 2024
Ver más
ETF relacionados
Hora de actualización: mié., 5 de mar
Hora de actualización: mié., 5 de mar
Nombre
Proporción
iShares U.S. Medical Devices ETF
18.53%
NYLI Healthy Hearts ETF
5.36%
Polen Capital Global Growth ETF
5.28%
Invesco Pharmaceuticals ETF
5.17%
Goldman Sachs Future Health Care Equity ETF
4.76%
Health Care Select Sector SPDR Fund
4.45%
AdvisorShares Focused Equity ETF
4.45%
Proshares Ultra Health Care
4.01%
iShares U.S. Healthcare ETF
3.87%
GMO US Quality ETF
3.59%
Ver más
iShares U.S. Medical Devices ETF
Proporción18.53%
NYLI Healthy Hearts ETF
Proporción5.36%
Polen Capital Global Growth ETF
Proporción5.28%
Invesco Pharmaceuticals ETF
Proporción5.17%
Goldman Sachs Future Health Care Equity ETF
Proporción4.76%
Health Care Select Sector SPDR Fund
Proporción4.45%
AdvisorShares Focused Equity ETF
Proporción4.45%
Proshares Ultra Health Care
Proporción4.01%
iShares U.S. Healthcare ETF
Proporción3.87%
GMO US Quality ETF
Proporción3.59%
Dividendos
Un total de
16.46B
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Dec 13, 2024
ABT.NB Interim Cash Dividend of gross USD 0.59 paid on Feb 14, 2025 going ex on Jan 15, 2025 with reinvestment option
Jan 15, 2025
Feb 14, 2025
Jan 15, 2025
Sep 19, 2024
ABT.NB Final Cash Dividend of gross USD 0.55 paid on Nov 15, 2024 going ex on Oct 15, 2024
Oct 15, 2024
Nov 15, 2024
Oct 15, 2024
Jun 15, 2024
ABT.NB Interim Cash Dividend of gross USD 0.55 paid on Aug 15, 2024 going ex on Jul 15, 2024 with reinvestment option
Jul 15, 2024
Aug 15, 2024
Jul 15, 2024
Feb 16, 2024
ABT.NB Interim Cash Dividend of gross USD 0.55 paid on May 15, 2024 going ex on Apr 12, 2024
Apr 15, 2024
May 15, 2024
Apr 12, 2024
Dec 15, 2023
ABT.NB Interim Cash Dividend of gross USD 0.55 paid on Feb 15, 2024 going ex on Jan 11, 2024 with reinvestment option
Jan 12, 2024
Feb 15, 2024
Jan 11, 2024
Sep 21, 2023
ABT.NB Final Cash Dividend of gross USD 0.51 paid on Nov 15, 2023 going ex on Oct 12, 2023 with reinvestment option
Oct 13, 2023
Nov 15, 2023
Oct 12, 2023
Jun 09, 2023
ABT.NB Interim Cash Dividend of gross USD 0.51 paid on Aug 15, 2023 going ex on Jul 13, 2023 with reinvestment option
Jul 14, 2023
Aug 15, 2023
Jul 13, 2023
Feb 17, 2023
ABT.NB Interim Cash Dividend of gross USD 0.51 paid on May 15, 2023 going ex on Apr 13, 2023 with reinvestment option
Apr 14, 2023
May 15, 2023
Apr 13, 2023
Dec 09, 2022
ABT.NB Interim Cash Dividend of gross USD 0.51 paid on Feb 15, 2023 going ex on Jan 12, 2023 with reinvestment option
Jan 13, 2023
Feb 15, 2023
Jan 12, 2023
Sep 15, 2022
ABT.NB Final Cash Dividend of gross USD 0.47 paid on Nov 15, 2022 going ex on Oct 13, 2022 with reinvestment option
Oct 14, 2022
Nov 15, 2022
Oct 13, 2022
Ver más
División de acciones
Fecha
Tipo
Relación

No datos encontrados
Fecha
Tipo
Relación

No datos encontrados